Carcinoma in situ of prostate

CD2_INSITU_PROSTATE

Grade III Prostatic Intraepithelial Neoplasia: High grade prostatic intraepithelial neoplasia characterized by the presence of severe architectural and cytologic abnormalities.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector
diagram bullet

Apply sex-specific rule

Sex only males

157571

diagram downward connector

Check conditions None

157571

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 D07.5&
Hospital discharge: ICD-9 2334
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 D07.5&
Cause of death: ICD-9 2334
Cause of death: ICD-8 $!$

27

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

27

diagram downward connector

Check minimum number of events None

27

diagram downward connector

Include endpoints None

27

diagram downward connector
CD2_INSITU_PROSTATE

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D07
Name in latin Carcinoma in situ prostatae

Summary Statistics

Key figures

All Female Male
Number of individuals 27 - 27
Unadjusted prevalence (%) 0.01 - 0.02
Mean age at first event (years) 70.54 - 70.54

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: CD2_INSITU_PROSTATE – Carcinoma in situ of prostate
GWS hits:

Survival analyses between endpoints

Plot

before Carcinoma in situ of prostate
after Carcinoma in situ of prostate

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Carcinoma in situ of prostate